Continue
By using our website you accept our cookies policy.Find out more

Cell and gene therapy bioprocessing and manufacture

Posted on 06/03/2019

A Cell and Gene Therapy Bioprocessing and Manufacture MBI course will run at UCL from 29 April – 1 May 2019.

Cell and gene therapy is fast becoming an established field that aims to utilise the power of cell-based medicines to deliver new therapies for the 21st Century. However, translating the discovery science into manufacturable products has so far been challenging and so multi-disciplinary engineers who possess unique skills are urgently needed to address the manufacture of these complex medicinal products.

The Cell and Gene Therapy Bioprocessing and Manufacture MBI course running at UCL from 29 April – 1 May 2019 addresses the real-world challenges of translating discoveries to the clinic in a way that is commercially viable. A series of lectures and interactive case studies will enable you to:

  • Understand the distinctions of manufacturing cells compared with biologics
  • Understand the challenges faced in advancing cell and gene therapies to clinic and the lessons learned from established companies
  • Understand the impact of design and engineering considerations on cell and gene therapy manufacture
  • Identify and define critical process parameters for different cell and gene therapy applications
  • Gain knowledge and application of analytical toolsets for quality measurement
  • Understand key implications to facilitate and expedite translation from laboratory to a manufacturing and clinical setting

The course has an exciting line up of speakers including:

  • Qasim Rafiq, UCL Biochemical Engineering
  • Suzanne Farid, UCL Biochemical Engineering
  • Vaughan Thomas, UCL Biochemical Engineering
  • Kenth Gustafsson, UCL Biochemical Engineering
  • Yasu Takeuchi, UCL Division of Infection and Immunity
  • Glyn Stacey, SSCBio and NIBSC
  • Damian Marshall, Cell and Gene Therapy Catapult
  • Julian Hanak, NightStar Therapeutics
  • Cancer Research UK

For further information on the Cell and Gene Therapy Bioprocessing and Manufacture MBI course running at UCL from 29 April – 1 May 2019, please click here.

About the MBI Industrial Training Programme

The award-winning MBI programme is the largest international provider of innovative, UCL-accredited short courses in bioprocessing, specifically created to support skills development of scientists and engineers working in the bioeng/bioprocess space or looking to move into these areas. All courses are designed and delivered in collaboration with 70 industrial experts to support continued professional and technical development. Courses are also integrated with departments’ cutting edge transnational research to ensure information is current and forms a platform for knowledge transfer. MBI is designed to be flexible with courses being taken stand-alone or combined for Certificate, Diploma or Masters Qualifications.

You can access a full list of courses here.